BPMX News and Press, BioPharmX Corporation. Common From 05/20/19

BioPharmX (NYSEMKT: BPMX ) -3% . More news on: BioPharmX Corporation, STMicroelectronics N.V., UP Fintech Holding Limited, Stocks on the move, Read more ...

Gainers:  Outlook Therapeutics (NASDAQ: OTLK ) +56% . Golden Bull (NASDAQ: DNJR ) +22% . Dunxin Financial Holdings (NYSEMKT: DXF ) +21% . Cray (NASDAQ: CRAY ) +19% . 21Vianet Group (NASDAQ: VNET ) +15% . Soliton (NASDAQ: SOLY ) +14% . Citius Pharmaceuticals (NASDAQ: CTXR ) +13%...

ChinaCache International (NASDAQ: CCIH ) -19% . More news on: ChinaCache International Holdings Ltd., Pinterest, Inc., Baidu, Inc., Stocks on the move, Read more ...

SAN JOSE, Calif. , April 26, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announces the completion of the reverse stock split previously announ...

SAN JOSE, Calif. , April 15, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that its Board of Directors has approved a reverse stock sp...

SAN JOSE, Calif. , March 21, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that it has entered into securities purchase agreements with certain institution...

CORAL GABLES, FL / ACCESSWIRE / March 4, 2019 / The healthcare stock market has managed to consistently garner significant amounts of attention over the course of the last few months, as more healthcare companies have focused their efforts on developing innovative care options for their pa...

SAN JOSE, Calif. , March 4, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that it has completed enrollment of its Phase 2b clinical trial with BPX-0...

CORAL GABLES, FL / ACCESSWIRE / February 28, 2019 / The tech stock market has been a hotbed of excitement as a result of companies in the tech industry working to develop innovative new products to revamp the quality of life enjoyed by consumers. is fueled by one of the most interesting em...

SAN JOSE, Calif. , Feb. 27, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, received a notice on February 25, 2019 from the NYSE American LLC (the "NYSE Am...